Latest News
AT&T Slides Again as Market Awaits Monday Test
AT&T shares fell 2.52% to $24.03 on Friday, marking a 4.5% weekly decline, as investors digest a rural coverage joint venture and FCC spectrum approval. Monday's session is seen as a key test for the stock.
Zoetis Hits New 52-Week Low Amid Steep Post-Earnings Decline
Zoetis closed at $74.22 on Friday, hitting a new 52-week low of $72.38, as the stock continues to slide following disappointing Q1 earnings and a reduced 2026 outlook.
Medtronic Hovers Near 52-Week Low as Market Awaits Earnings
Medtronic shares closed at $76.15, near their 52-week low, as broader market weakness weighed ahead of the company's June 3 earnings report.
Babcock & Wilcox stock offering tests rally after 50% weekly surge
Babcock & Wilcox closes $200M stock offering at $18.50 after shares surged 50% on Q1 revenue growth and AI data center demand. Investors watch for dilution impact Monday.
McCormick Shares Test Key Support Ahead of Unilever Deal Vote
McCormick shares slipped to $46.35 after touching a weekly low of $44.82, as the market awaits Monday's session to determine if the Unilever deal pressure intensifies.
Hyliion Stock Surges 90% on Q1 Earnings, KARNO Progress
Hyliion shares surged nearly 90% this week after Q1 revenue of $2.8 million and progress on its KARNO power module. The stock closed at $4.67 on Friday.
NuScale Power Faces Critical Monday After Steep Weekly Decline
NuScale Power shares dropped 6.88% Friday to $11.23, capping a 10.5% weekly loss. Citi cut its target to $7 (Sell), Northland to $19 (Outperform). Q1 revenue fell sharply; net loss widened.
SpaceX IPO Buzz Fuels Tema NASA ETF Weekly Rally
Tema NASA ETF rose 7.5% for the week despite a 3.9% Friday drop, as SpaceX IPO buzz and a potential Nasdaq listing drive investor interest.
Natera Shares Slide Despite FDA Approval for Bladder Cancer Test
Natera shares dropped 5.36% Friday, even after the FDA approved its Signatera CDx test for use with Genentech's Tecentriq in muscle-invasive bladder cancer. The stock closed at $186.36.
